Skip to main content
. 2018 Oct 12;9:2270. doi: 10.3389/fimmu.2018.02270

Figure 1.

Figure 1

Regulatory mechanisms of EV biogenesis, release, and uptake. Exosome release can be inhibited by interfering their biogenesis (e.g., ceramide production) or the membrane fusion of the multivesicular endosome (MVE) with the plasma membrane (e.g., Rab27). Once EVs are released to the extracellular milieu, their uptake can be blocked by interfering the EV-plasma membrane protein interactions (e.g., Tetraspanins), clathrin- and caveolin-dependent endocytosos (e.g., Dynasore), phagocytosis (e.g., Wortmannin), and by inhibiting lipid-raft mediated endocytosis (e.g., Filipin). DFMO, difluoromethylornithine; DMA, dimethyl amiloride; ESCRT, endosomal sorting complex required for transport; EVs, extracellular vesicles; HSPG, heparan sulfate proteoglycans; ICAM-1, intercellular adhesion molecule 1; MβCD, methyl-β-cyclodextrin; nSMase, neutral sphingomyelinase; PS, phosphatidylserine.